At the end of 2024, Darwin Bio and Beijing Tiantan Hospital of Capital Medical University signed a contract on the transfer of results in the "Innovation and Entrepreneurship Competition and Transformation Results Project Signing Ceremony". The meeting was hosted by Wang Yilong, Executive Vice President of Tiantan Hospital, and many experts and scholars gathered to witness this important moment.
(Wang Yilong, Executive Vice President and Standing Committee of the Party Committee, Beijing Tiantan Hospital)
Yan Ying, Director of the Beijing Municipal Science and Technology Commission's Achievement Transformation Department, and Liu Wanying, Executive Deputy Director of the Fengtai District Medicine and Health Specialized Class, were among the experts in attendance.At the meeting, Yan Ying and Director Liu Wanying delivered speeches, highly praised the efforts of Tiantan Hospital in the field of science and technology innovation, and expected that through the activities to stimulate innovative thinking, accelerate the transformation of scientific and technological achievements, to solve the clinical problems, and to benefit the patients.
(Yan Ying, Director, Department of Achievement Transformation, Beijing Municipal Science and Technology Commission)
(Ms. Liu Wanying, Executive Deputy Director of the Fengtai District Medical and Health Specialized Group)
The signing of this contract, as the closing achievement of Darwin Bio in 2024, adds another exciting year's effort to the team. The transfer of this achievement marks an important milestone event in the scientific research and clinical research between our company and Tiantan Hospital and the National Neurological Clinical Center, and the process and testing of innovative biological agents and the expansion of clinical diseases have achieved further expansion and enhancement. Mitochondrial disease, as a rare disease, has no therapeutic drugs due to the impairment of mitochondrial function, which involves multiple organ systems and triggers a variety of symptoms. The identification of this result further validates that Darwin BioNeuroRepair Preparation has an extremely outstanding performance in whole nerve function repair.